The Equine PeptideAtlas: A resource for developing proteomics-based veterinary research

Proteomics

Volumn 14, Issue 6, 2014, Pages 763-773

  Bundgaard, Louise ^a,c   Jacobsen, Stine ^a   Sørensen, Mette A ^a   Sun, Zhi ^b   Deutsch, Eric W ^b   Moritz, Robert L ^b   Bendixen, Emøke ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Acute phase proteins; Animal proteomics; Equine; PeptideAtlas; Proteotypic peptides

Indexed keywords

ACUTE PHASE PROTEIN; FIBRINOGEN; HAPTOGLOBIN; SERUM AMYLOID A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FLUID; CONTROLLED STUDY; DATA MINING; EQUIDAE; EQUINE PEPTIDEATLAS; NONHUMAN; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TANDEM MASS SPECTROMETRY; VETERINARY MEDICINE;

ACUTE PHASE PROTEINS; ANIMAL PROTEOMICS; EQUINE; PEPTIDEATLAS; PROTEOTYPIC PEPTIDES;

AMINO ACID SEQUENCE; ANIMALS; DATA MINING; DATABASES, PROTEIN; HORSE DISEASES; HORSES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84895732362     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300398     Document Type: Article

References (66)

1. Barton, C., Beck, P., Kay, R., Teale, P., Roberts, J., Multiplexed LC-MS/MS analysis of horse plasma proteins to study doping in sport. Proteomics 2009, 9, 3058-3065.
2. Bouwman, F. G., van Ginneken, M. M., Noben, J. P., Royackers, E. et al., Differential expression of equine muscle biopsy proteins during normal training and intensified training in young standardbred horses using proteomics technology. Comp. Biochem. Physiol. Part D. Genomics Proteomics 2010, 5, 55-64.
3. Clutterbuck, A. L., Smith, J. R., Allaway, D., Harris, P. et al., High throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammation. J. Proteomics 2011, 74, 704-715.
4. Saalmuller, A., Lunney, J. K., Daubenberger, C., Davis, W. et al., Summary of the animal homologue section of HLDA8. Cell. Immunol. 2005, 236, 51-58.
5. Deutsch, E. W., The PeptideAtlas Project. Methods Mol. Biol. 2010, 604, 285-296.
6. Vizcaino, J. A., Cote, R., Reisinger, F., Foster, J. M. et al., A guide to the Proteomics Identifications Database proteomics data repository. Proteomics 2009, 9, 4276-4283.
7. Craig, R., Cortens, J. P., Beavis, R. C., Open source system for analyzing, validating, and storing protein identification data. J. Proteome Res. 2004, 3, 1234-1242.
8. Deutsch, E. W., Mendoza, L., Shteynberg, D., Farrah, T. et al., A guided tour of the Trans-Proteomic Pipeline. Proteomics 2010, 10, 1150-1159.
9. Loevenich, S. N., Brunner, E., King, N. L., Deutsch, E. W. et al., The Drosophila melanogaster PeptideAtlas facilitates the use of peptide data for improved fly proteomics and genome annotation. BMC Bioinformatics 2009, 1471-2105-10-59.
10. Bislev, S. L., Deutsch, E. W., Sun, Z., Farrah, T. et al., A Bovine PeptideAtlas of milk and mammary gland proteomes. Proteomics 2012, 12, 2895-2899.
11. Jacobsen, S., Andersen, P. H., The acute phase protein serum amyloid A (SAA) as a marker of inflammation in horses. Equine Vet. Educ. 2007, 19, 36-46.
12. Gabay, C., Kushner, I., Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340, 448-454.
13. Petersen, H. H., Nielsen, J. P., Heegaard, P. M., Application of acute phase protein measurements in veterinary clinical chemistry. Vet. Res. 2004, 35, 163-187.
14. Pihl, T. H., Andersen, P. H., Kjelgaard-Hansen, M., Morck, N. B., Jacobsen, S., Serum amyloid A and haptoglobin concentrations in serum and peritoneal fluid of healthy horses and horses with acute abdominal pain. Vet. Clin. Pathol. 2013, 42, 177-183.
15. Jacobsen, S., Nielsen, J. V., Kjelgaard-Hansen, M., Toelboell, T. et al., Acute phase response to surgery of varying intensity in horses: a preliminary study. Vet. Surg. 2009, 38, 762-769.
16. Deutsch, E. W., Lam, H., Aebersold, R., PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep. 2008, 9, 429-434.
17. Deutsch, E. W., Mass spectrometer output file format mzML. Methods Mol. Biol. 2010, 604, 319-331.
18. Yates, J. R., 3rd, Eng, J. K., McCormack, A. L., Schieltz, D., Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 1995, 67, 1426-1436.
19. Craig, R., Beavis, R. C., TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004, 20, 1466-1467.
20. Keller, A., Eng, J., Zhang, N., Li, X. J., Aebersold, R., A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol. Syst. Biol. 2005, 1, 2005.0017.
21. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
22. Shteynberg, D., Deutsch, E. W., Lam, H., Eng, J. K. et al., iProphet: multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates. Mol. Cell. Proteomics 2011, 10, M111.007690.
23. Reiter, L., Claassen, M., Schrimpf, S. P., Jovanovic, M. et al., Protein identification false discovery rates for very large proteomics data sets generated by tandem mass spectrometry. Mol. Cell. Proteomics 2009, 8, 2405-2417.
24. Farrah, T., Deutsch, E. W., Aebersold, R., Using the Human Plasma PeptideAtlas to study human plasma proteins. Methods Mol. Biol. 2011, 728, 349-374.
25. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
26. Murata, H., Shimada, N., Yoshioka, M., Current research on acute phase proteins in veterinary diagnosis: an overview. Vet. J. 2004, 168, 28-40.
27. Wolf, C. A., Maslchitzky, E., Gregory, R. M., Jobim, M. I., Mattos, R. C., Effect of corticotherapy on proteomics of endometrial fluid from mares susceptible to persistent postbreeding endometritis. Theriogenology 2012, 77, 1351-1359.
28. Moore, R. E., Knottenbelt, D., Matthews, J. B., Beynon, R. J., Whitfield, P. D., Biomarkers for ragwort poisoning in horses: identification of protein targets. BMC Vet. Res. 2008, 4, 30-6148-4-30.
29. Taharaguchi, S., Nagano, A., Okai, K., Miyasho, T. et al., Detection of an isoform of alpha(1)-antitrypsin in serum samples from foals with gastric ulcers. Vet. Rec. 2007, 161, 338-342.
30. Jacobsen, S., Jensen, J. C., Frei, S., Jensen, A. L., Thoefner, M. B., Use of serum amyloid A and other acute phase reactants to monitor the inflammatory response after castration in horses: a field study. Equine Vet. J. 2005, 37, 552-556.
31. Hulten, C., Gronlund, U., Hirvonen, J., Tulamo, R. M. et al., Dynamics in serum of the inflammatory markers serum amyloid A (SAA), haptoglobin, fibrinogen and alpha2-globulins during induced noninfectious arthritis in the horse. Equine Vet. J. 2002, 34, 699-704.
32. Jacobsen, S., Thomsen, M. H., Nanni, S., Concentrations of serum amyloid A in serum and synovial fluid from healthy horses and horses with joint disease. Am. J. Vet. Res. 2006, 67, 1738-1742.
33. Hobo, S., Niwa, H., Anzai, T., Evaluation of serum amyloid A and surfactant protein D in sera for identification of the clinical condition of horses with bacterial pneumonia. J. Vet. Med. Sci. 2007, 69, 827-830.
34. Lavoie-Lamoureux, A., Leclere, M., Lemos, K., Wagner, B., Lavoie, J. P., Markers of systemic inflammation in horses with heaves. J. Vet. Intern. Med. 2012, 26, 1419-1426.
35. Jacobsen, S., Niewold, T. A., Halling-Thomsen, M., Nanni, S. et al., Serum amyloid A isoforms in serum and synovial fluid in horses with lipopolysaccharide-induced arthritis. Vet. Immunol. Immunopathol. 2006, 110, 325-330.
36. McDonald, T. L., Larson, M. A., Mack, D. R., Weber, A., Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A 3 (M-SAA3) into colostrum. Vet. Immunol. Immunopathol. 2001, 83, 203-211.
37. Berg, L. C., Thomsen, P. D., Andersen, P. H., Jensen, H. E., Jacobsen, S., Serum amyloid A is expressed in histologically normal tissues from horses and cattle. Vet. Immunol. Immunopathol. 2011, 144, 155-159.
38. Kjelgaard-Hansen, M., Christensen, M. B., Lee, M. H., Jensen, A. L., Jacobsen, S., Serum amyloid A isoforms in serum and synovial fluid from spontaneously diseased dogs with joint diseases or other conditions. Vet. Immunol. Immunopathol. 2007, 117, 296-301.
39. Christoffersen, M., Baagoe, C. D., Jacobsen, S., Bojesen, A. M. et al., Evaluation of the systemic acute phase response and endometrial gene expression of serum amyloid A and pro- and anti-inflammatory cytokines in mares with experimentally induced endometritis. Vet. Immunol. Immunopathol. 2010, 138, 95-105.
40. Sung, H. J., Jeon, S. A., Ahn, J. M., Seul, K. J. et al., Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera. J. Proteomics 2012, 75, 2170-2180.
41. Kjelgaard-Hansen, M., Jacobsen, S., Assay validation and diagnostic applications of major acute-phase protein testing in companion animals. Clin. Lab. Med. 2011, 31, 51-70.
42. Borges, A. S., Divers, T. J., Stokol, T., Mohammed, O. H., Serum iron and plasma fibrinogen concentrations as indicators of systemic inflammatory diseases in horses. J. Vet. Intern. Med. 2007, 21, 489-494.
43. Copas, V. E., Durham, A. E., Stratford, C. H., McGorum, B. C. et al., In equine grass sickness, serum amyloid A and fibrinogen are elevated, and can aid differential diagnosis from non-inflammatory causes of colic. Vet. Rec. 2013, 172, 395.
44. Weisel, J. W., Fibrinogen and fibrin. Adv. Protein Chem. 2005, 70, 247-299.
45. Andersen, S. A., Petersen, H. H., Ersboll, A. K., Falk-Ronne, J., Jacobsen, S., Vaccination elicits a prominent acute phase response in horses. Vet. J. 2012, 191, 199-202.
46. Sobel, J. H., Thibodeau, C. A., Kolks, M. A., Canfield, R. E., Isolation and partial structural characterization of an equine fibrinogen CNBr fragment that exhibits immunologic cross-reactivity with an A alpha-chain cross-linking region of human fibrinogen. Biochemistry 1990, 29, 8907-8916.
47. Riedel, T., Suttnar, J., Brynda, E., Houska, M. et al., Fibrinopeptides A and B release in the process of surface fibrin formation. Blood 2011, 117, 1700-1706.
48. Boisclair, M. D., Ireland, H., Lane, D. A., Assessment of hypercoagulable states by measurement of activation fragments and peptides. Blood Rev. 1990, 4, 25-40.
49. Gando, S., Tedo, I., Diagnostic and prognostic value of fibrinopeptides in patients with clinically suspected pulmonary embolism. Thromb. Res. 1994, 75, 195-202.
50. Hellgren, M., Hemostasis during normal pregnancy and puerperium. Semin. Thromb. Hemost. 2003, 29, 125-130.
51. Gouin-Thibault, I., Samama, M. M., Laboratory diagnosis of the thrombophilic state in cancer patients. Semin. Thromb. Hemost. 1999, 25, 167-172.
52. Schoffel, U., Zeller, T., Lausen, M., Ruf, G., Farthmann, E. H., Monitoring of the inflammatory response in early peritonitis. Am. J. Surg. 1989, 157, 567-572.
53. Nelson, K., Thethi, I., Cunanan, J., Hoppensteadt, D. et al., Upregulation of surrogate markers of inflammation and thrombogenesis in patients with ESRD: pathophysiologic and therapeutic implications. Clin. Appl. Thromb. Hemost. 2011, 17, 302-304.
54. Erban, J. K., Wagner, D. D., A 130-kDa protein on endothelial cells binds to amino acids 15-42 of the B beta chain of fibrinogen. J. Biol. Chem. 1992, 267, 2451-2458.
55. Skogen, W. F., Senior, R. M., Griffin, G. L., Wilner, G. D., Fibrinogen-derived peptide B beta 1-42 is a multidomained neutrophil chemoattractant. Blood 1988, 71, 1475-1479.
56. Petzelbauer, P., Zacharowski, P. A., Miyazaki, Y., Friedl, P. et al., The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat. Med. 2005, 11, 298-304.
57. Taira, T., Fujinaga, T., Okumura, M., Yamashita, K. et al., Equine haptoglobin: isolation, characterization, and the effects of ageing, delivery and inflammation on its serum concentration. J. Vet. Med. Sci. 1992, 54, 435-442.
58. Wicher, K. B., Fries, E., Evolutionary aspects of hemoglobin scavengers. Antioxid. Redox Signal. 2010, 12, 249-259.
59. Quaye, I. K., Haptoglobin, inflammation and disease. Trans. R. Soc. Trop. Med. Hyg. 2008, 102, 735-742.
60. Morimatsu, M., Syuto, B., Shimada, N., Fujinaga, T. et al., Isolation and characterization of bovine haptoglobin from acute phase sera. J. Biol. Chem. 1991, 266, 11833-11837.
61. Schwantes, A. R., Tondo, C. V., Preliminary data on haptoglobin in vertebrates. Braz. J. Med. Biol. Res. 1969, 2, 105-107.
62. Angelucci, S., Ciavardelli, D., Di Giuseppe, F., Eleuterio, E. et al., Proteome analysis of human follicular fluid. Biochim. Biophys. Acta 2006, 1764, 1775-1785.
63. Richards, J. S., Russell, D. L., Ochsner, S., Espey, L. L., Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol. 2002, 64, 69-92.
64. Yamada, M., Gentry, P. A., The hemostatic profile of equine ovarian follicular fluid. Thromb. Res. 1995, 77, 45-54.
65. Parrott, J. A., Whaley, P. D., Skinner, M. K., Extrahepatic expression of fibrinogen by granulosa cells: potential role in ovulation. Endocrinology 1993, 133, 1645-1649.
66. Estes, S. J., Ye, B., Qiu, W., Cramer, D. et al., A proteomic analysis of IVF follicular fluid in women ≤ 32 years old. Fertil. Steril. 2009, 92, 1569-1578.